Cargando…

PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non‐small cell lung cancer

BACKGROUND: Pappalysin 2 (PAPPA2) mutation, occurring most frequently in skin cutaneous melanoma (SKCM) and non‐small cell lung cancer (NSCLC), is found to be related to anti‐tumour immune response. However, the association between PAPPA2 and the efficacy of immune checkpoint inhibitors (ICIs) thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yiting, Zhao, Lele, Duan, Jianchun, Bai, Hua, Chen, Dongsheng, Li, Si, Yu, Yangyang, Xiao, Mingzhe, Zhang, Qin, Duan, Qianqian, Sun, Tingting, Qi, Chuang, Wang, Jie, Wang, Zhijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436912/ https://www.ncbi.nlm.nih.gov/pubmed/35811392 http://dx.doi.org/10.1111/cpr.13283

Ejemplares similares

Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR
por: Sifakis, Stavros, et al.
Publicado: (2018)

Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy
por: Zhao, Jie, et al.
Publicado: (2023)

Symposium on Aspect of Nuclear Science : Festschrift Pappas (Alexis Constantin)
por: Hagebo, Einar, et al.
Publicado: (1987)

Pappa2 deletion in mice affects male but not female fertility
por: Christians, Julian K., et al.
Publicado: (2015)

Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer
por: Wan, Rui, et al.
Publicado: (2023)

Identification of fatty acid metabolism–related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Altered placental expression of PAPPA2 does not affect birth weight in mice
por: Wagner, Pamela K, et al.
Publicado: (2010)

Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression
por: Zhang, Jun, et al.
Publicado: (2022)

Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
por: Mao, Rui, et al.
Publicado: (2021)

Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC
por: Sun, Yiting, et al.
Publicado: (2021)

PAPPA2 as a Therapeutic Modulator of IGF-I Bioavailability: in Vivo and in Vitro Evidence
por: Andrew, Melissa, et al.
Publicado: (2018)

Novel Prognostic Biomarkers in Gastric Cancer: CGB5, MKNK2, and PAPPA2
por: Qin, Min, et al.
Publicado: (2021)

Generation and Application of Inducible Chimeric RNA ASTN2-PAPPA(as) Knockin Mouse Model
por: Luo, Yichen, et al.
Publicado: (2022)

PAPPA Expression in Indeterminate Thyroid Nodules as Screening Test to Select Patients for Molecular Testing
por: Marzocchi, Carlotta, et al.
Publicado: (2022)

NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma
por: Li, Hongxia, et al.
Publicado: (2022)

Combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer
por: Wang, Zhen, et al.
Publicado: (2021)

Total Knee Replacement Arthroplasty with Buechel and Pappas Knee: Minimum 2-Year Follow-up
por: Moon, Kyoung Ho, et al.
Publicado: (2015)

Genetic Study of IL6, GDF5 and PAPPA2 in Association with Developmental Dysplasia of the Hip
por: Harsanyi, Stefan, et al.
Publicado: (2021)

PAPPA2 Promote the Proliferation of Dermal Papilla Cells in Hu Sheep (Ovis aries) by Regulating IGFBP5
por: Wu, Tianyi, et al.
Publicado: (2021)

Blockade of STAT3/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via suppressing M2 macrophages polarization
por: Sun, Yiting, et al.
Publicado: (2022)

Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer
por: Du, Jun, et al.
Publicado: (2021)

lncRNA PAPPA-AS1 Induces the Development of Hypertrophic Scar by Upregulating TLR4 through Interacting with TAF15
por: Fan, Pengju, et al.
Publicado: (2021)

Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma
por: Ma, Dongshen, et al.
Publicado: (2022)

Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
por: Dong, Yiting, et al.
Publicado: (2022)

A Replication Study for the Association of rs726252 in PAPPA2 with Developmental Dysplasia of the Hip in Chinese Han Population
por: Shi, Dongquan, et al.
Publicado: (2014)

Placental DNA methylation at term reflects maternal serum levels of INHA and FN1, but not PAPPA, early in pregnancy
por: Wilson, Samantha L., et al.
Publicado: (2015)

Down-regulated circPAPPA suppresses the proliferation and invasion of trophoblast cells via the miR-384/STAT3 pathway
por: Zhou, Wenbo, et al.
Publicado: (2019)

Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients
por: Hirshoren, Nir, et al.
Publicado: (2020)

Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non–small cell lung cancers
por: Han, Jiefei, et al.
Publicado: (2021)

Recombinant IGF-1 Induces Sex-Specific Changes in Bone Composition and Remodeling in Adult Mice with Pappa2 Deficiency
por: Rubio, Leticia, et al.
Publicado: (2021)

Sus_circPAPPA2 Regulates Fat Deposition in Castrated Pigs through the miR-2366/GK Pathway
por: Liu, Ximing, et al.
Publicado: (2022)

Clinical value of Melanoma Inhibitory Activity in stratifying malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015)

mTOR regulates the expression of DNA damage response enzymes in long‐lived Snell dwarf, GHRKO, and PAPPA‐KO mice
por: Dominick, Graham, et al.
Publicado: (2016)

Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma
por: Zhu, Zheng, et al.
Publicado: (2022)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

Beneficiary Perspective
por: Davis, Karen
Publicado: (1996)

Beneficiaries of Rehabilitation
por: Bickenbach, Jerome, et al.
Publicado: (2021)

Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
por: Yan, Junya, et al.
Publicado: (2023)

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
por: Tomsitz, Dirk, et al.
Publicado: (2022)

Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a human placental trophoblast cell line (BeWo)
por: Wagner, Pamela K, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_34lffp8l68qun8fkunc1ehcu8v